SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories purchases land to set up new formulations facility

02 Jan 2025 Evaluate

Ind-Swift Laboratories has completed the purchase of land admeasuring around 40 Bighas located at Punjab, for a total consideration of Rs 17.72 crore (including stamp duty). This land will be utilized for setting up a new state-of-the-art formulations’ facility.

Earlier, the company had completed the acquisition of land at Dera Bassi, Punjab for a total consideration of Rs 1.93 crore for setting up of a new state-of-the-art Research and Development (R&D) Centre.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).

Ind-Swift Labs. Share Price

246.40 11.30 (4.81%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: